(Q33765659)

29 July 2017

Risk factors for low bone mineral density in children and young adults with Crohn's disease (English)

1 reference

29 July 2017

0 references

Semeao EJ

1

1 reference

29 July 2017

Jawad AF

2

1 reference

29 July 2017

Stouffer NO

3

1 reference

29 July 2017

Zemel BS

4

1 reference

29 July 2017

Piccoli DA

5

1 reference

29 July 2017

Stallings VA

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

The Journal of Pediatrics

29 July 2017

1 reference

29 July 2017

135

1 reference

29 July 2017

5

1 reference

29 July 2017

593-600

1 reference

THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Reduced bone density in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

A controlled study of bone mineral density in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Low bone mineral density in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Epidemiology of osteoporosis and osteoporotic fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Mineral accretion in growing bones--a framework for the future?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Bone mineral density assessment in children with inflammatory bowel disease☆☆☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Inflammatory bowel disease and predisposition to osteopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Interpretation of bone mineral density values in pediatric Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Metabolic bone assessment in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Colitis causes bone loss in rats through suppression of bone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Effects of tumor necrosis factor on bone formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Interleukin-1 beta is a potent inhibitor of bone formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Pathogenesis and treatment of steroid osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970058-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(99)70058-2

1 reference

29 July 2017

1 reference